ORTX
Price:
$16.7
Market Cap:
$380.11M
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's disease through a single administration. It provides Strimvelis, a gammaretroviral-based product for the treatment of adenosine deaminase-severe combined immunodeficiency (ADA-SCID). The company's clinical development products comprise OTL-101 for the treatment of ADA-SCID; OTL-200 to treat metachromatic leukodystrophy; OTL-103 for the treatment of Wis...[Read more]
Industry
Biotechnology
IPO Date
2018-10-31
Stock Exchange
NASDAQ
Ticker
ORTX
According to Orchard Therapeutics plc’s latest financial reports and current stock price. The company's current PE Ratio is -4.07. This represents a change of 282.60% compared to the average of -1.06 of the last 4 quarters.
The mean historical PE Ratio of Orchard Therapeutics plc over the last ten years is -4.81. The current -4.07 PE Ratio has changed 8.37% with respect to the historical average. Over the past ten years (40 quarters), ORTX's PE Ratio was at its highest in in the December 2022 quarter at 0.09. The PE Ratio was at its lowest in in the December 2018 quarter at -13.47.
Average
-4.81
Median
-4.50
Minimum
-7.85
Maximum
-1.54
Discovering the peaks and valleys of Orchard Therapeutics plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 409.57%
Maximum Annual PE Ratio = -1.54
Minimum Annual Increase = -63.97%
Minimum Annual PE Ratio = -7.85
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -6.01 | 33.43% |
| 2021 | -4.50 | 59.25% |
| 2020 | -2.83 | -63.97% |
| 2019 | -7.85 | 409.57% |
| 2018 | -1.54 | -56.71% |
| 2017 | -3.56 | -51.98% |
The current PE Ratio of Orchard Therapeutics plc (ORTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.45
5-year avg
-4.54
10-year avg
-4.81
Orchard Therapeutics plc’s PE Ratio is greater than Vigil Neuroscience, Inc. (-4.16), less than Checkpoint Therapeutics, Inc. (-0.05), greater than Revance Therapeutics, Inc. (-5.24), greater than G1 Therapeutics, Inc. (-7.72), less than Climb Bio, Inc. (-2.50), greater than Y-mAbs Therapeutics, Inc. (-17.56), less than scPharmaceuticals Inc. (-3.32), less than iTeos Therapeutics, Inc. (-2.18), less than SomaLogic, Inc. (-3.54), less than Claritev Corporation (-1.78),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.16 | $375.71M | |
| -0.05 | $367.72M | |
| -5.24 | $381.02M | |
| -7.72 | $377.75M | |
| -2.50 | $117.96M | |
| -17.56 | $391.22M | |
| -3.32 | $302.20M | |
| -2.18 | $448.68M | |
| -3.54 | $396.23M | |
| -1.78 | $610.62M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orchard Therapeutics plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Orchard Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Orchard Therapeutics plc's PE Ratio?
How is the PE Ratio calculated for Orchard Therapeutics plc (ORTX)?
What is the highest PE Ratio for Orchard Therapeutics plc (ORTX)?
What is the 3-year average PE Ratio for Orchard Therapeutics plc (ORTX)?
What is the 5-year average PE Ratio for Orchard Therapeutics plc (ORTX)?
How does the current PE Ratio for Orchard Therapeutics plc (ORTX) compare to its historical average?